Home
Conditions
Adenocarcinoma

Clinical trial condition

Adenocarcinoma

Explore clinical trials studying Adenocarcinoma. Study availability and eligibility vary by location and protocol.

5,027 public trials 1,169 recruiting studies

Refine in advanced search Browse all conditions

Adenocarcinoma trial results

Active, Not Recruiting

Selpercatinib Before Surgery for the Treatment of RET-Altered Thyroid Cancer

NCT04759911

Conditions: Adenocarcinoma, Adenocarcinoma, Papillary, Carcinoma, +25 more
Locations: Johns Hopkins University/Sidney Kimmel Cancer Center Baltimore, Maryland, United States

University of Michigan Health Systems Ann Arbor, Michigan, United States

M D Anderson Cancer Center Houston, Texas, United States

View Trial Details

Active, Not Recruiting

Study Investigating the Association of NP137 With Atezolizumab-Bevacizumab Combination in First Line in Unresectable HCC

NCT05546879

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +9 more
Locations: CHU de GRENOBLE ALPES Grenoble, Alpes, France

CHU Angers Angers, France

Hôpital Haut Lêveque Bordeaux, France

12 Hôpital St Joseph Marseille, France

View Trial Details

Active, Not Recruiting

DS3201 and Ipilimumab for the Treatment of Metastatic Prostate, Urothelial and Renal Cell Cancers

NCT04388852

Conditions: Adenocarcinoma, Aggressive Variant Prostate Carcinoma, Carcinoma, +34 more
Locations: M D Anderson Cancer Center Houston, Texas, United States

View Trial Details

Active, Not Recruiting

Liver Ablative Radiotherapy Utilising Kilovoltage Intrafraction Monitoring (KIM)

NCT02984566

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +9 more
Locations: Nepean Hospital Penrith, New South Wales, Australia

Westmead Hospital Westmead, New South Wales, Australia

Princess Alexandra Hospital Woolloongabba, Queensland, Australia

Peter MacCallum Cancer Centre Melbourne, Victoria, Australia

View Trial Details

Active, Not Recruiting

Cadonilimab (AK104) Plus Lenvatinib in Previously Immunotherapy-Treated Advanced/Metastatic Clear Cell Renal Cell Carcinoma

NCT06035224

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +14 more
Locations: Shanghai Renji Hospital Shanghai, Shanghai Municipality, China

View Trial Details

Active, Not Recruiting

A Study of Belzutifan (MK-6482) Plus Pembrolizumab (MK-3475) Versus Placebo Plus Pembrolizumab in Participants With Clear Cell Renal Cell Carcinoma Post Nephrectomy (MK-6482-022)

NCT05239728

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +14 more
Locations: Mayo Clinic in Arizona - Phoenix ( Site 3554) Phoenix, Arizona, United States

City of Hope Comprehensive Cancer Center ( Site 3567) Duarte, California, United States

Moores Cancer Center-Clinical Trials Office- Genitourinary ( Site 3516) La Jolla, California, United States

UCLA Hematology/Oncology - Westwood (Building 200 Suite 140)-Department of Urology/Institute of Uro ( Site 3520) Los Angeles, California, United States

View all 285 locations

View Trial Details

Active, Not Recruiting

Dose Escalation and Dose Expansion Study of RMC-6291 Monotherapy in Subjects With Advanced KRASG12C Mutant Solid Tumors

NCT05462717

Conditions: Adenocarcinoma, Adnexal Diseases, Advanced Solid Tumor, +60 more
Locations: Highlands Oncology Group Springdale, Arkansas, United States

UC Irvine Cancer Center Orange, California, United States

UC Davis Cancer Center Sacramento, California, United States

UCSF San Francisco, California, United States

View all 64 locations

View Trial Details

Active, Not Recruiting

A Study of Belzutifan (MK-6482) Versus Everolimus in Participants With Advanced Renal Cell Carcinoma (MK-6482-005)

NCT04195750

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +13 more
Locations: Faculty Office Towers 1132 ( Site 1538) Birmingham, Alabama, United States

University of California San Diego Moores Cancer Center ( Site 1546) La Jolla, California, United States

St. Joseph Heritage Healthcare Local Lab ( Site 1531) Santa Rosa, California, United States

University of Colorado Cancer Center ( Site 1540) Aurora, Colorado, United States

View all 172 locations

View Trial Details

Active, Not Recruiting

Radiomics Subtyping to Guide Surgery vs. Maintenance Therapy After HCC Downstaging

NCT07581769

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +14 more
Locations: The First Affiiated Hospital of Sun Yat-sen University Guangzhou, Guangdong, China

Zhujiang Hospital of Southern Medical University Guangzhou, Guangdong, China

View Trial Details

Active, Not Recruiting

Multicenter Trial of ESK981 in Patients With Select Solid Tumors

NCT05988918

Conditions: Adenocarcinoma, Adenoma, Adenoma, Islet Cell, +27 more
Locations: Rogel Cancer Center Ann Arbor, Michigan, United States

University of Wisconsin Carbone Cancer Center Madison, Wisconsin, United States

View Trial Details

Adenocarcinoma

Adenocarcinoma trial results

Related conditions